JP7672704B2 - インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技 - Google Patents

インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技 Download PDF

Info

Publication number
JP7672704B2
JP7672704B2 JP2021559803A JP2021559803A JP7672704B2 JP 7672704 B2 JP7672704 B2 JP 7672704B2 JP 2021559803 A JP2021559803 A JP 2021559803A JP 2021559803 A JP2021559803 A JP 2021559803A JP 7672704 B2 JP7672704 B2 JP 7672704B2
Authority
JP
Japan
Prior art keywords
lymph nodes
subject
needle
cells
endoscope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021559803A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020210710A5 (https=
JP2022528921A (ja
JP2022528921A5 (https=
Inventor
エリック ラガッセ，
パウロ アルトゥール チャベス フォンテス，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of JP2022528921A publication Critical patent/JP2022528921A/ja
Publication of JPWO2020210710A5 publication Critical patent/JPWO2020210710A5/ja
Publication of JP2022528921A5 publication Critical patent/JP2022528921A5/ja
Priority to JP2024119461A priority Critical patent/JP2024144606A/ja
Application granted granted Critical
Publication of JP7672704B2 publication Critical patent/JP7672704B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B10/04—Endoscopic instruments, e.g. catheter-type instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3403—Needle locating or guiding means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3472—Trocars; Puncturing needles for bones, e.g. intraosseus injections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3478—Endoscopic needles, e.g. for infusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00969—Surgical instruments, devices or methods used for transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3403—Needle locating or guiding means
    • A61B2017/3413—Needle locating or guiding means guided by ultrasound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36—Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37—Surgical systems with images on a monitor during operation
    • A61B2090/376—Surgical systems with images on a monitor during operation using X-rays, e.g. fluoroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36—Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37—Surgical systems with images on a monitor during operation
    • A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/26—Materials or treatment for tissue regeneration for kidney reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/28—Materials or treatment for tissue regeneration for liver reconstruction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pathology (AREA)
  • Transplantation (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
JP2021559803A 2019-04-11 2020-04-10 インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技 Active JP7672704B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024119461A JP2024144606A (ja) 2019-04-11 2024-07-25 インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962832492P 2019-04-11 2019-04-11
US62/832,492 2019-04-11
PCT/US2020/027783 WO2020210710A1 (en) 2019-04-11 2020-04-10 Minimally invasive cell transplant procedure to induce the development of in vivo organogenesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024119461A Division JP2024144606A (ja) 2019-04-11 2024-07-25 インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技

Publications (4)

Publication Number Publication Date
JP2022528921A JP2022528921A (ja) 2022-06-16
JPWO2020210710A5 JPWO2020210710A5 (https=) 2023-04-21
JP2022528921A5 JP2022528921A5 (https=) 2023-04-21
JP7672704B2 true JP7672704B2 (ja) 2025-05-08

Family

ID=72752119

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021559803A Active JP7672704B2 (ja) 2019-04-11 2020-04-10 インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技
JP2024119461A Pending JP2024144606A (ja) 2019-04-11 2024-07-25 インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024119461A Pending JP2024144606A (ja) 2019-04-11 2024-07-25 インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技

Country Status (13)

Country Link
US (1) US12569276B2 (https=)
EP (2) EP4427813A3 (https=)
JP (2) JP7672704B2 (https=)
KR (1) KR20210155390A (https=)
CN (1) CN114340646A (https=)
AU (1) AU2020271121B2 (https=)
BR (1) BR112021020451A2 (https=)
CA (1) CA3136471A1 (https=)
ES (1) ES2983230T3 (https=)
GB (1) GB2600256B (https=)
IL (2) IL324627A (https=)
MX (1) MX2021012314A (https=)
WO (1) WO2020210710A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023023353A1 (en) * 2021-08-19 2023-02-23 Kassab Ghassan S Intranodal needle and method of using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015145354A (ja) 2014-02-04 2015-08-13 国立大学法人名古屋大学 高濃度脂肪組織由来間葉系幹細胞含有脂肪による声門閉鎖不全の治療
WO2018152488A1 (en) 2017-02-17 2018-08-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610288B1 (en) 1995-05-26 2003-08-26 Diacrin, Inc. Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function
US6154560A (en) 1996-08-30 2000-11-28 The Cleveland Clinic Foundation System and method for staging regional lymph nodes using quantitative analysis of endoscopic ultrasound images
JP2000107299A (ja) * 1998-10-06 2000-04-18 Machida Endscope Co Ltd 内視鏡用注射針装置
SG155053A1 (en) 2002-07-19 2009-09-30 Vesta Therapeutics Inc Method of obtaining viable human liver cells, including hepatic stem/progenitor cells
US7653427B2 (en) 2004-11-12 2010-01-26 Intra-Medical Imaging LLC Method and instrument for minimally invasive sentinel lymph node location and biopsy
US7824376B2 (en) * 2004-12-24 2010-11-02 Olympus Corporation Injection needle apparatus for making injection in tissue in body cavity
US7804990B2 (en) 2006-01-25 2010-09-28 Siemens Medical Solutions Usa, Inc. System and method for labeling and identifying lymph nodes in medical images
US11191785B2 (en) * 2008-03-07 2021-12-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
WO2014138486A1 (en) * 2013-03-06 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
WO2009111778A2 (en) 2008-03-07 2009-09-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph nodes as a site for regeneration
US20120045764A1 (en) 2009-05-01 2012-02-23 Markus Grompe Method of expanding human hepatocytes in vivo
WO2013069143A1 (ja) * 2011-11-10 2013-05-16 株式会社高研 超音波気管支内視鏡用トレーニングモデル
CN202761247U (zh) * 2012-07-25 2013-03-06 西安交通大学医学院第一附属医院 一种医用内窥镜注射器
CN113913366B (zh) * 2013-02-18 2025-01-10 大学健康网络 由多能干细胞生成肝细胞和胆管细胞的方法
US9533013B2 (en) * 2013-03-13 2017-01-03 University Of North Carolina At Chapel Hill Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
EP4299721A3 (en) 2013-05-08 2024-04-24 ProKidney Organoids comprising isolated renal cells and uses thereof
SG10202009095VA (en) * 2014-11-26 2020-10-29 Accelerated Biosciences Corp Induced hepatocytes and uses thereof
JP6594133B2 (ja) * 2015-09-16 2019-10-23 富士フイルム株式会社 内視鏡位置特定装置、内視鏡位置特定装置の作動方法および内視鏡位置特定プログラム
WO2018134729A1 (en) 2017-01-18 2018-07-26 Technion Research & Development Foundation Ltd. Sparsity-based ultrasound super-resolution imaging
EP4349263B1 (en) 2017-05-31 2026-03-04 Mayo Foundation for Medical Education and Research Methods for super-resolution ultrasound imaging of microvessels
EP3634514A4 (en) 2017-06-09 2021-03-10 President and Fellows of Harvard College METHODS FOR IMPROVING THE DEVELOPMENT OF RENAL ORGANOIDS AND METHODS OF USING THEREOF
WO2019006127A1 (en) 2017-06-28 2019-01-03 Rutgers, The State University Of New Jersey ORGANOIDS DERIVED FROM A SINGLE RENAL CELL
US10456164B2 (en) * 2017-10-02 2019-10-29 URO-1, Inc. Anti-microbial medical injection assemblies for onabotulinumtoxina delivery and methods of use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015145354A (ja) 2014-02-04 2015-08-13 国立大学法人名古屋大学 高濃度脂肪組織由来間葉系幹細胞含有脂肪による声門閉鎖不全の治療
WO2018152488A1 (en) 2017-02-17 2018-08-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CANCER，2000年，Vol.88, No.6，pp.1325-1335
IRISAWA A. et al.，Endoscopic Ultrasound-Guided Fine Needle Injection of Immature Dendritic Cells into Advanced Pancreatic Carcinoma Refractory to Gemcitabine: A Pilot Study，GASTROINTESTINAL ENDOSCOPY，2005年，Vol.61, No.5，p.AB283 W1219
NATURE BIOTECHNOLOGY，2012年，Vol.30, No.10，pp.976-985，doi:10.1038/nbt.2379
肝臓，2011年，Vol.52, No.10，pp.671-678
胆と膵，2009年，Vol.30臨時増刊特大号，pp.1257-1261

Also Published As

Publication number Publication date
GB2600256A (en) 2022-04-27
ES2983230T3 (es) 2024-10-22
GB202115372D0 (en) 2021-12-08
AU2020271121B2 (en) 2024-04-11
EP3952895B8 (en) 2024-07-17
EP3952895B1 (en) 2024-06-05
EP4427813A2 (en) 2024-09-11
JP2022528921A (ja) 2022-06-16
EP4427813A3 (en) 2024-12-18
US12569276B2 (en) 2026-03-10
MX2021012314A (es) 2021-11-12
CA3136471A1 (en) 2020-10-15
US20220096126A1 (en) 2022-03-31
IL287125A (en) 2021-12-01
GB2600256B (en) 2024-02-21
BR112021020451A2 (pt) 2022-03-08
EP3952895A4 (en) 2022-12-28
KR20210155390A (ko) 2021-12-22
JP2024144606A (ja) 2024-10-11
IL324627A (en) 2026-01-01
WO2020210710A1 (en) 2020-10-15
AU2020271121A1 (en) 2021-11-04
EP3952895A1 (en) 2022-02-16
CN114340646A (zh) 2022-04-12

Similar Documents

Publication Publication Date Title
Citro et al. Biofabrication of a vascularized islet organ for type 1 diabetes
JP7185527B2 (ja) ミトコンドリアおよび組み合わされたミトコンドリア剤の治療的使用
US7846728B2 (en) Tissue engineering in vivo with vascularized scaffolds
US20140314724A1 (en) Cell preparation for erectile dysfunction or sensory disorders of the lower urinary tract containing adipose tissue derived mesenchymal stem cells
Sundaram et al. Esophageal regeneration following surgical implantation of a tissue engineered esophageal implant in a pediatric model
JP2024144606A (ja) インビボ器官形成の発生を誘導するための最小侵襲の細胞移植手技
JP2023058660A (ja) リンパ管新生促進因子発現線維芽細胞及びそれを含む医薬組成物
Vons et al. First description of the surgical anatomy of the cynomolgus monkey liver
Wiet et al. Seeding and implantation of a biosynthetic tissue-engineered tracheal graft in a mouse model
Matthias et al. Skeletal muscle perfusion and stem cell delivery in muscle disorders using intra-femoral artery canulation in mice
Dun et al. Combined abdominal heterotopic heart and aorta transplant model in mice
HK40070239A (en) Minimally invasive cell transplant procedure to induce the development of in vivo organogenesis
Han et al. Bone marrow-derived mesenchymal stem cells enhance cryopreserved trachea allograft epithelium regeneration and vascular endothelial growth factor expression
JP6383938B2 (ja) 高濃度脂肪組織由来間葉系幹細胞含有脂肪による声門閉鎖不全の治療
JP6213976B2 (ja) 膵外分泌機能不全のモデル動物
US20220226392A1 (en) Compositions and process for integrating cells into epithelium
Tracy et al. Lung rehabilitation using xenogeneic cross-circulation does not lead to hyperacute rejection in a human lung transplantation model
Shen et al. Cystoplasty Combined Autologous Peritoneum with Ileal Seromuscular segment: a new model study
García-Domínguez et al. Embryonic organ transplantation: the new era of xenotransplantation
CN112514853B (zh) 一种多发性骨髓瘤合并慢性移植物抗宿主病小鼠模型的建立方法
Yang et al. Stem cell therapy for necrotizing enterocolitis: innovative techniques and procedures for pediatric translational research
Wang et al. Feasibility and Short-Term Stability of Portal Vein Infusion Port Placement by Transjugular Access
Wen et al. Establishment of a novel volume-loaded heterotopic heart transplantation model in rats
Nishimuta et al. Development of new treatment strategy for bronchopleural fistula using the bio-plug created with the bio-3D printer
JPWO2020210710A5 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230320

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230320

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230413

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240126

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240425

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240625

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250407

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250416

R150 Certificate of patent or registration of utility model

Ref document number: 7672704

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150